Retrospective analysis of patients’ experience to intravesical Bacillus Calmette-Guerin (BCG)

Why?
•
Gold standard
•
Bladder cancer incidence rates are highest in developed countries, especially Northern America and Europe
•
BCG treatment induction & maintenance has significant benefits, but also has significant side effects that tend to be seen within the first 12 months of treatment
•
To analyse the reasons for treatment interruption in everyday clinical practice in a large district hospital